Makalah Kasus 5 Hpv

  • Published on
    01-Mar-2018

  • View
    215

  • Download
    0

Embed Size (px)

Transcript

  • 7/26/2019 Makalah Kasus 5 Hpv

    1/37

    KELOMPOK X

    Seorang Wanita yang Ingin Melakukan Vaksin Kanker Serviks

    Modul Organ Sistem Reproduksi

    03009030 ARUMTYAS CAHYANING W

    03009040 AYUNDA AFDAL

    03009060 DELITA SAFIRA DANA

    03009070 DIANITA KUSUMA WIJAYA

    03009080 EVA MARIS SAHARA

    03009090 FIRDHA AQMARINA

    03009100 GADISTA P ANNISA

    03009110 HEN!A AYU PRIMALITA

    03009111 HERJUN" DARPIT"

    030091#1 INDRASTITI PRAMITASARI

    03009130 KHRISNA PARAMAARTHA

    03009131 KIKI HAERA RI!KY

    03009138 M EVAN EWALD"

    03009140 MADE AYU INTAN WINAYATI "

    FK!L"S KE#OK"ER$ !$IVERSI"S "RISK"I

    %KR" &' %$!RI ()'(

  • 7/26/2019 Makalah Kasus 5 Hpv

    2/37

    ** I

    PE$#+!L!$

    K$%&'( )'(*+&) ,'(-.$&$% &'/$%$)$% .'($,$ $%/ ,'%'($%/ 2$%+$ '(-$,$ +

    %'/$($%'/$($ 5'(&',5$%/ K$%&'( )'(*+&) $$- -/$ +&'%$ '%/$% &$%&'( ''( ($+,

    ,'(-.$&$% &$%&'( $%/ 5'($)$ $(+ )'(*+&) -'(+ :+$)$%$ )'5$/+$% 5')$( &$)-) $$%/

    &' (-,$ )$&+ $$, )$+-, $%- &$('%$ .$$ )$+-, +%+ +$& +',-&$% /'$$

    /'$$ $%/ ).')+;+&

    P'%'5$5 '()'(+%/ $(+ &$%&'( )'(*+&) +%+ $$$ +%;'&)+ $(+ *+(-) HPV T'$.+ +$&

    )',-$ *+(-) HPV 5'()+;$ &$()+%'$( ''=+

  • 7/26/2019 Makalah Kasus 5 Hpv

    3/37

    ** II

    LPOR$ KS!S

    Sesi '

    S'? ,$))$ >?

    E&)(',+$)@ A&($ $%/$ $/$& .-=$ '',$ >?

    S$-) /+%'&? +$&-&$% .$.),'$( $% &',-+$%

    3

  • 7/26/2019 Makalah Kasus 5 Hpv

    4/37

    +$&-&$% ') IVA $)+ >?

    V$/+%$

  • 7/26/2019 Makalah Kasus 5 Hpv

    5/37

    PEM*+S$

    :'($)$(&$% &$)-) +$.$&$% +%;

  • 7/26/2019 Makalah Kasus 5 Hpv

    6/37

    /$$ ($)$ '(5$&$( &','($$% .'(- +=-(+/$+ $.$&$ +)'5$5&$% +%;'&)+

    ,+&(

  • 7/26/2019 Makalah Kasus 5 Hpv

    7/37

    g, Ri0ayat Keluarga

    4 A.$&$ $$ &'-$(/$ $%/ ,'%/$$,+ (+2$$ .'%$&+ $%-%/ /+%$ +$5'')

    ,'+-) $$- .'%$&+ $+%%$

    4 A.$&$ '($.$ (+2$$ &'/$%$)$% $$, &'-$(/$

    4 A.$&$ +5- .$)+'% $$- )$-$($ .'(',.-$% '(&'%$ &$%&'( )'(*+&)

    -, Ri0ayat Pengo/atan

    4 A.$&$

  • 7/26/2019 Makalah Kasus 5 Hpv

    8/37

    P'(%$.$)$% @ #0 B,'%+

    N

  • 7/26/2019 Makalah Kasus 5 Hpv

    9/37

    P$.$)+ &''%$( :'(

  • 7/26/2019 Makalah Kasus 5 Hpv

    10/37

    ' V$/+%$ T? N"RMAL

    &,6 Pemeriksaan Penun7ang

    , La/oratorium

    1 H5 118 /B >N1#14?

    H5 .$$ .$)+'% ,'%-(-% )'+&+ .$)+'% $$, &'$$$% $%',+$

    # L'-&N00010000?

    L'-&

  • 7/26/2019 Makalah Kasus 5 Hpv

    11/37

    Pemeriksaan Penun7ang "am/a-an

    A K?5? C$ )'(*+ @ >? .$)-

    $%/ 5+)$ +)'5$5&$%

    &$('%$ )'$%/ $$,

    &'$$$% ,'%)(-$)+

    5'(-5-%/$% )' 3

    $(+ )'5'-,

    .','(+&)$$% $$-

  • 7/26/2019 Makalah Kasus 5 Hpv

    12/37

    +.4?

    P$.),'$( +$& (-+%

    K'.-+$% ;-?

    M'(

  • 7/26/2019 Makalah Kasus 5 Hpv

    13/37

    )'(+%/ ,'(.($&$%&'(? )' $5%

  • 7/26/2019 Makalah Kasus 5 Hpv

    14/37

    C'-'(

    C$%/')

    N'/$+; ASCUS LGSIL HGSIL HGSIL C$(=+%(+2$$ .$(-) 4?

    MER"K"K >;$&.'&'($$% )-.+( (-&?

    R')+&< +%//+ I%;'&)+ HPV

    S

  • 7/26/2019 Makalah Kasus 5 Hpv

    15/37

    HPV ,'(-.$&$% +=HPV?

    15

    GEN"ME YANG PALING:ERPERAN DALAM

    REPLIKASI VIRUS HPV

    DALAM SEL :ASAL

    EPITEL CERVI

    P$(+&' *+(-) HPV

    ,'%/+%;'&)+ )' '.+'+$

    )'(*+&) ,'$-+ ,+=(L1L#?

    T'(5'%-& VIRI"N >$%$& *+(-

    $%/ 5$(-?+&'-$(&$% $(.'(,-&$$% )-$,

  • 7/26/2019 Makalah Kasus 5 Hpv

    16/37

    P$$ P','(+&)$$% P$.),'$( +$.$&$% $)+ )+

    16

    REPLIKSI VIR!S @@

    =sel immatur>

    L')+ .($&$%&'( NIS II

    >HGSIL? .$$ .$.),'$(

    $% IVA >?

    T+,5-&$% /'$$ '-&?

    S-$ ,'%=$.$+ #B3

    5$/+$% $$) '.+'

  • 7/26/2019 Makalah Kasus 5 Hpv

    17/37

    '5+ 5')$( $(+.$$ )+

  • 7/26/2019 Makalah Kasus 5 Hpv

    18/37

    S-$,+ .$)+'% $%/ ,',++&+ .'&'($$% )'5$/$+ )-.+( (-& $%$( &

  • 7/26/2019 Makalah Kasus 5 Hpv

    19/37

    A%+.',5')$($% 640 &$+? K

  • 7/26/2019 Makalah Kasus 5 Hpv

    20/37

    E&)+)+

  • 7/26/2019 Makalah Kasus 5 Hpv

    21/37

    P(

  • 7/26/2019 Makalah Kasus 5 Hpv

    22/37

    c. T+$& 5'('%$%/ )'$,$ 5'5'($.$ ,+%//-

    d. P$)+'% +,+%$ -%-& )'/'($ ,'%/-5-%/+ '%/$% $$- $%.$ &

  • 7/26/2019 Makalah Kasus 5 Hpv

    23/37

    +$.$&$% ')+ .($ &$%&'( ,=$)) III? $%/ +-%-&&$% '%/$%

    $$%$ HSIL $% NIS #

  • 7/26/2019 Makalah Kasus 5 Hpv

    24/37

    &5$- $,+)? 5'(2$(%$ &'$5-$5-$%

    :'5'($.$ '%+) 5$&'(+ $+% -/$ ,',+=- ,-%=-%$ .'%$&+ &'$,+%Gonococcus $$- '5+ +&'%$ '%/$% %$,$ G" W$(%$%$ &'&-%+%/$% ,'(-.$&$%

    %$%$ $%/ '(+(+ $(+ '-&

  • 7/26/2019 Makalah Kasus 5 Hpv

    25/37

    5$&'(+ .$'%='( &'%$? '(/$%-%/ $(+ )+&-)

  • 7/26/2019 Makalah Kasus 5 Hpv

    26/37

    Pengo/atan dan pen1ega-an

    P'%/

  • 7/26/2019 Makalah Kasus 5 Hpv

    27/37

    *+(-) +%+ +$& 5'()'-5-%/ V+(-) +%+ ,'%/+%;'&)+ )' .+.+ '.+'+-, $% ,'%'5$5&$%

    &'$$$% +.'(.$)+$ $(+ )' '.+' .+.+

    V+(-) +%+ ,',++&+ '5+ $(+ 100 +.' + ,$%$ )'5$/+$% 5')$( + $%$($%$

    +$& 5'(5$$$ $% $&$% +$%/ '%/$% )+)', +,-% $%/ $'&-$ $&$% '$.+ )'&+$( 30

    '%+) 5'(')+&< -%-& &$%&'( S'+%//$ +&$)+;+&$)+&$% )'5$/$+ (+)+&< +%//+

    &',-%/&+%$% (+)+&< +%//+ $% (+)+&< ('%$ R+)+&< ('%$ $.$ ,'%'5$5&$% &-+

    &'$,+% )'$%/&$% (+)+&< +%//+ ,'%'5$5&$% &$%&'( )'(*+&) *-*$ *$/+%$ $% $%-)

    .$$ 2$%+$ )'($ &$%&'( $%-) $% .'%+) .$$ .(+$ P'%'5$5 '(5$%$& C$ )'(*+&) $$$

    +.' 16 $% 18 T'$.+ )'$+% +)'5$5&$%

  • 7/26/2019 Makalah Kasus 5 Hpv

    28/37

    T'($.$ 3 &

  • 7/26/2019 Makalah Kasus 5 Hpv

    29/37

    S''$ ,'%$+ &$%&'( )'(*+&) '($.$ .',5$/+$% )$+-,%$ )'5$/$+ 5'(+&-@

    Stadium ), K$()+%=

  • 7/26/2019 Makalah Kasus 5 Hpv

    30/37

    A.$5+$ &$%&'( )-$ ,'%'5$( &' .$%//- ,$&$ .$)+'% $&$% ,'%'(+$ &'-$%

    %'(+ .-%//-%/

    -/$ $,5$$% $$, 5'(&',+ )'($ .',5')$($% /+%$

    S'+%//$ .'(- +$&-&$% ''&)+ +%+ '%/$% ,'$&-&$% .$. ),'$( $+- )-$-

    ,'

  • 7/26/2019 Makalah Kasus 5 Hpv

    31/37

    '%/$% )')' %

  • 7/26/2019 Makalah Kasus 5 Hpv

    32/37

    P'%/

  • 7/26/2019 Makalah Kasus 5 Hpv

    33/37

    )'(*+&) -'(-) P',5'(+$% *$&)+% .$$ $&+$&+ +$.89?%enis vaksin :+*$'% >16 18? $% -$(+*$'% >16 18 6 11? HPV 16 $% HPV

    18 ,'(-.$&$% HPV (+)+&< +%//+ >&$()+%%&$()+%+)$($%&$% -)+$ 1# $-%? :'-, =-&-. $$';'&+*+$) .',5'(+$% *$&)+% HPV .$$ $&+$&+

    E3ektivitas P$$ .'%'++$% ;$)' II .(HPV +.' 16 $% 18? ,',.-%$+ .(

  • 7/26/2019 Makalah Kasus 5 Hpv

    34/37

    (cross protection) '($$. HPV +.' 4 >'%/$% ';'&+*+$) 94? $% HPV +.' 31

    >'%/$% ';'&+*+$) ?

    Populasi target :'($)$(&$% .-)$&$ *$&)+% +5'(+&$% .$$ .'(',.-$% -)+$ $%$($ 9#6

    $-% >('&+ %'/$($ U%+ E(

  • 7/26/2019 Makalah Kasus 5 Hpv

    35/37

    ** V

    KESIMP!L$

    P$$ &$)-) &$+ +%+ $$$ )'

  • 7/26/2019 Makalah Kasus 5 Hpv

    36/37

    S'$+% +- (+2$$ .$)+'% $%/ ,'$+(&$% )'5$%$& ',.$ &$+ -/$ '(,$)-& $$,

    ;$&)'.'(+ =

  • 7/26/2019 Makalah Kasus 5 Hpv

    37/37

    A=='))' #9 J$%-$( #01#

    4 C'(*+=$ C$%='( U.$' N